ProMIS Neurosciences, Inc.

PMN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$11,580-$10,117-$7,348-$238
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$212$0$623
Change in WC$1,323$6,051$2,176-$3,356
Other Non-Cash$76$0$245-$5,263
Operating Cash Flow-$10,182-$3,854-$4,927-$8,233
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$33,051
Inv. Sales/Matur.$0$0$0$32,358
Other Inv. Act.$0$0$0$692
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$21,263$0$0$470
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$461
Financing Cash Flow$21,263$0$0$9
Forex Effect-$192$0-$0-$21
Net Chg. in Cash$10,889-$3,854-$4,927-$8,246
Supplemental Information
Beg. Cash$4,510$8,364$13,291$21,537
End Cash$15,399$4,510$8,364$13,291
Free Cash Flow-$10,182-$3,854-$4,927-$8,233
ProMIS Neurosciences, Inc. (PMN) Financial Statements & Key Stats | AlphaPilot